The DOI matches its Crossref record; 3,517 of the 3,517 references it cites were found in a registry or an index.
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 1,001–1,200 of 3,517
Harper, D. G., Stopa, E. G., McKee, A. C., Satlin, A., Harlan, P. C., Goldstein, R., & Volicer, L. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.353 · Cited by 230
Evolutionary radiations and convergences in the structural organization of mammalian brains
de Winter, W., & Oxnard, C. E. (2001) · Nature · doi:10.1038/35055547 · Cited by 229
Clinical use of quetiapine in disease states other than schizophrenia.
Dl, D., Laird, L. K., Zajecka, J., Bailey, L., Sussman, N., & Seabolt, J. L. (2002) · PubMed · Cited by 229
Nitric oxide and penile erectile function
TODA, N., AYAJIKI, K., & OKAMURA, T. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.011 · Cited by 229
Role of Estrogen in the Aetiology and Treatment of Mood Disorders
Halbreich, U., & Kahn, L. S. (2001) · CNS Drugs · doi:10.2165/00023210-200115100-00005 · Cited by 229
Zhang, H. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00344-5 · Cited by 229
Translocation and Reversible Localization of Signaling Proteins
Teruel, M. N., & Meyer, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00109-4 · Cited by 229
Antidepressant-like effect of the neurosteroid 3α-hydroxy-5α-pregnan-20-one in mice forced swim test
Khisti, R. T., Chopde, C. T., & Jain, S. P. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00300-2 · Cited by 229
The impact of systems approaches on biological problems in drug discovery
Hood, L., & Perlmutter, R. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1004-1215 · Cited by 229
Gill, T. M., Sarter, M., & Givens, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04745.2000 · Cited by 228
Zhu, C.-B., Carneiro, A. M., Dostmann, W. R., Hewlett, W. A., & Blakely, R. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410858200 · Cited by 228
Taché, Y., Martinez, V, Wang, L., & Million, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705760 · Cited by 228
Vizi, E. S., & Lendvai, B. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00016-8 · Cited by 228
Contarino, A., Dellu, F., Koob, G. F., Smith, G. W., Lee, K.-F., Vale, W., & Gold, L. H. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01158-5 · Cited by 228
Redistribution of GABAB(1)Protein and Atypical GABABResponses in GABAB(2)-Deficient Mice
Gassmann, M., Shaban, H., Vigot, R., Sansig, G., Haller, C., Barbieri, S., Humeau, Y., Schuler, V., Müller, M., Kinzel, B., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5635-03.2004 · Cited by 228
Trazodone for antidepressant-associated insomnia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.1069 · Cited by 227
Ganguly, R., Kotzan, J. A., Miller, L. S., Kennedy, K., & Martin, B. C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1013 · Cited by 227
Bhagwagar, Z., Wylezinska, M., Taylor, M., Jezzard, P., Matthews, P. M., & Cowen, P. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.368 · Cited by 227
Serotonin mediates oestrogen stimulation of cell proliferation in the adult dentate gyrus
Banasr, M., Hery, M., Brezun, J. M., & Daszuta, A. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01763.x · Cited by 226
Rational Approach To Discover Multipotent Anti-Alzheimer Drugs
Rosini, M., Andrisano, V., Bartolini, M., Bolognesi, M. L., Hrelia, P., Minarini, A., Tarozzi, A., & Melchiorre, C. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049112h · Cited by 226
Trophic Control of Production in a Rocky Intertidal Community
Paine, R. T. (2002) · Science · doi:10.1126/science.1069811 · Cited by 226
NMDA receptors as targets for drug action in neuropathic pain
Parsons, C. G. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01307-3 · Cited by 226
Bourin, M., Mocaër, E., & Porsolt, R. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0414 · Cited by 226
Antidepressant-like actions of an AMPA receptor potentiator (LY392098)
Li, X., Tizzano, J. P., Griffey, K., Clay, M., Lindstrom, T., & Skolnick, P. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00194-5 · Cited by 225
From monoamines to genomic targets: a paradigm shift for drug discovery in depression
Wong, M.-L., & Licinio, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1303 · Cited by 225
Information exchange and the robustness of organizational networks
Dodds, P. S., Watts, D. J., & Sabel, C. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1534702100 · Cited by 225
Strategies for managing sexual dysfunction induced by antidepressant medication
Taylor, M. J., Rudkin, L., Bullemor-Day, P., Lubin, J., Chukwujekwu, C., & Hawton, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003382.pub3 · Cited by 225
Malleret, G., Hen, R., Guillou, J.-L., Segu, L., & Buhot, M.-C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-06157.1999 · Cited by 224
5-HT2A and 5-HT2C receptors and their atypical regulation properties
Van Oekelen, D., Luyten, W. H. M. L., & Leysen, J. E. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00141-3 · Cited by 224
The supramammillary area: its organization, functions and relationship to the hippocampus
Pan, W.-X., & McNaughton, N. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.003 · Cited by 223
Cryan, J. F., Bruijnzeel, A. W., Skjei, K. L., & Markou, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1445-7 · Cited by 223
Maurice, T., Urani, A., Phan, V.-L., & Romieu, P. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00112-6 · Cited by 223
AMPA Receptor Potentiators for the Treatment of CNS Disorders
O'Neill, M., Bleakman, D., Zimmerman, D., & Nisenbaum, E. (2004) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007043337508 · Cited by 223
Heidinger, V., Manzerra, P., Wang, X. Q., Strasser, U., Yu, S.-P., Choi, D. W., & Behrens, M. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05452.2002 · Cited by 223
Bergink, V (2004) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00100-7 · Cited by 223
A question of size: the eukaryotic proteome and the problems in defining it
Harrison, P. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.5.1083 · Cited by 222
Clinical Applications of MAO-Inhibitors
Riederer, P., Lachenmayer, L., & Laux, G. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364775 · Cited by 222
Giacobini, E., Spiegel, R., Enz, A., Veroff, A. E., & Cutler, N. R. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200089 · Cited by 222
Picciotto, M. R., Caldarone, B. J., Brunzell, D. H., Zachariou, V., Stevens, T. R., & King, S. L. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00161-9 · Cited by 221
Ogden, C. A., Rich, M. E., Schork, N. J., Paulus, M. P., Geyer, M. A., Lohr, J. B., Kuczenski, R., & Niculescu, A. B. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001547 · Cited by 221
Bodnoff, S. R., Suranyi-Cadotte, B., Quirion, R., & Meaney, M. J. (1989) · Psychopharmacology · doi:10.1007/bf00442264 · Cited by 221
Rahman, S., Nestor, P. J., Hodges, J. R., Sahakian, B. J., & Deakin, J. B. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1686-5 · Cited by 221
Reagan, L. P., Rosell, D. R., Wood, G. E., Spedding, M., Muñoz, C., Rothstein, J., & McEwen, B. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307294101 · Cited by 221
Zill, P., Büttner, A., Eisenmenger, W., Möller, H.-J., Bondy, B., & Ackenheil, M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.015 · Cited by 221
Millan, M. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2199-1 · Cited by 221
Self-citationDuteil, J., Rambert, F. A., Pessonnier, J., Hermant, J.-F., Gombert, R., & Assous, E. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90591-s · Cited by 220
The neutral theory of molecular evolution and the world view of the neutralists
Kimura, M. (1989) · Genome · doi:10.1139/g89-009 · Cited by 220
The societal costs of chronic major depression.
Pincus, H. A., & Pettit, A. R. (2001) · PubMed · Cited by 219
The Effect of Antidepressant Treatment on Chronic Back Pain: A Meta-analysis
Salerno, S. M., Browning, R., & Jackson, J. L. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.1.19 · Cited by 219
Sibutramine: A Review of its Contribution to the Management of Obesity
McNeely, W., & Goa, K. L. (1998) · Drugs · doi:10.2165/00003495-199856060-00019 · Cited by 219
Eshleman, A. J., Carmolli, M., Cumbay, M., Martens, C. R., Neve, K. A., & Janowsky, A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38214-x · Cited by 219
Wright, C. I., Geula, C., & Mesulam, M. ‐. (1993) · Annals of Neurology · doi:10.1002/ana.410340312 · Cited by 219
Di Giovanni, G., De Deurwaerdére, P., Di Mascio, M., Di Matteo, V, Esposito, E., & Spampinato, U. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00655-1 · Cited by 218
Rumi, D. O., Gattaz, W. F., Rigonatti, S. P., Rosa, M. A., Fregni, F., Rosa, M. O., Mansur, C., Myczkowski, M. L., Moreno, R. A., & Marcolin, M. A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.029 · Cited by 218
Regulation of Extracellular Dopamine by the Norepinephrine Transporter
Yamamoto, B. K., & Novotney, S. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010274.x · Cited by 218
Young, J. W., Finlayson, K., Spratt, C., Marston, H. M., Crawford, N., Kelly, J. S., & Sharkey, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300393 · Cited by 218
Hajós, M., Fleishaker, J. C., Filipiak‐Reisner, J. K., Brown, M. T., & Wong, E. H. F. (2004) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2004.tb00002.x · Cited by 218
Arresting developments in heptahelical receptor signaling and regulation
Perry, S. J., & Lefkowitz, R. J. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02239-5 · Cited by 218
TMS Induced Plasticity in Human Cortex
Ziemann, U. (2004) · Reviews in the Neurosciences · doi:10.1515/revneuro.2004.15.4.253 · Cited by 218
Vesicular Localization and Activity-Dependent Trafficking of Presynaptic Choline Transporters
Ferguson, S. M., Savchenko, V., Apparsundaram, S., Zwick, M., Wright, J., Heilman, C. J., Yi, H., Levey, A. I., & Blakely, R. D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-30-09697.2003 · Cited by 218
Lowy, M. T., Wittenberg, L., & Yamamoto, B. K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010268.x · Cited by 217
Baker, K. G., Halliday, G. M., Hornung, J.-P., Geffen, L. B., Cotton, R. G. H., & To¨rk, I. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90043-n · Cited by 217
Robust and tissue-specific expression of TPH2 versus TPH1 in rat raphe and pineal gland
Patel, P. D., Pontrello, C., & Burke, S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.09.002 · Cited by 217
Schramm, N. L., McDonald, M. P., & Limbird, L. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-13-04875.2001 · Cited by 217
Implications of adult hippocampal neurogenesis in antidepressant action
Malberg, J. E. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0422 · Cited by 217
5-HT and antidepressants: new views from microdialysis studies
Artigas, F. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90125-4 · Cited by 215
Barann, M., Molderings, G., Brüss, M., Bönisch, H., Urban, B. W., & Göthert, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704829 · Cited by 215
Rodrigues, S. M., Bauer, E. P., Farb, C. R., Schafe, G. E., & LeDoux, J. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-05219.2002 · Cited by 215
Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs
Joyce, J. N. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00139-5 · Cited by 214
Tsai, S., Cheng, C., Yu, Y. W., Chen, T., & Hong, C. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20026 · Cited by 214
Seeger, T., Fedorova, I., Zheng, F., Miyakawa, T., Koustova, E., Gomeza, J., Basile, A. S., Alzheimer, C., & Wess, J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3581-04.2004 · Cited by 214
Elevation of the Cortisol-Dehydroepiandrosterone Ratio in Drug-Free Depressed Patients
Young, A. H., Gallagher, P., & Porter, R. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1237 · Cited by 214
Stahl, S. M., Zhang, L., Damatarca, C., & Grady, M. M. (2003) · PubMed · Cited by 213
Rybakowski, J. K., & Twardowska, K. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00014-x · Cited by 213
The Burden of Major Depression Avoidable by Longer-term Treatment Strategies
Vos, T., Haby, M. M., Barendregt, J. J., Kruijshaar, M., Corry, J., & Andrews, G. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1097 · Cited by 213
The reality of comorbidity: Depression and drug abuse
Volkow, N. D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.007 · Cited by 213
Samuvel, D. J., Jayanthi, L. D., Bhat, N. R., & Ramamoorthy, S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3754-04.2005 · Cited by 213
The DSM-IV field trial for mixed anxiety-depression
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.8.1153 · Cited by 213
In Vivo Gene Modification Elucidates Subtype-Specific Functions of α2-Adrenergic Receptors
Kable, J. W., Murrin, L. C., & Bylund, D. B. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39196-7 · Cited by 213
Klein, D. N., Schatzberg, A. F., McCullough, J. P., Dowling, F., Goodman, D., Howland, R. H., Markowitz, J. C., Smith, C., Thase, M. E., Rush, A. J., et al. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00020-8 · Cited by 212
Rowlett, J. K., Platt, D. M., Lelas, S., Atack, J. R., & Dawson, G. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405621102 · Cited by 212
Feng, J., Cai, X., Zhao, J., & Yan, Z. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06502.2001 · Cited by 212
Imipramine Treatment of Alcoholics With Primary Depression: A Placebo-Controlled Clinical Trial
McGrath, P. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830030054009 · Cited by 212
SSRI-Induced extrapyramidal side-effects and akathisia: implications for treatment
Lane, R. M. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200212 · Cited by 212
Nurnberg, H. G., Hensley, P. L., Gelenberg, A. J., Fava, M., Lauriello, J., & Paine, S. (2003) · JAMA · doi:10.1001/jama.289.1.56 · Cited by 212
Wagner, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4387 · Cited by 212
11β-Hydroxysteroid Dehydrogenase in the Brain: A Novel Regulator of Glucocorticoid Action?
Seckl, J. R. (1997) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1996.0143 · Cited by 212
Yaffe, K., Krueger, K., Cummings, S. R., Blackwell, T., Henderson, V. W., Sarkar, S., Ensrud, K., & Grady, D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.683 · Cited by 212
Damaj, M. I., Carroll, F. I., Eaton, J. B., Navarro, H. A., Blough, B. E., Mirza, S., Lukas, R. J., & Martin, B. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001313 · Cited by 212
Antidepressant-Like Effect of Different Estrogenic Compounds in the Forced Swimming Test
Estrada-Camarena, E., Fernández-Guasti, A., & López-Rubalcava, C. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300097 · Cited by 211
Gal, C. S.-L., Wagnon, J., Simiand, J., Griebel, G., Lacour, C., Guillon, G., Barberis, C., Brossard, G., Soubrié, P., Nisato, D., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.1122 · Cited by 211
Evidence-based pharmacotherapy of obsessive–compulsive disorder
Fineberg, N. A., & Gale, T. M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004675 · Cited by 211
Central neural regulation of penile erection
Giuliano, F., & Rampin, O. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00020-8 · Cited by 210
Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonist
Gether, U., Johansen, T. E., Snider, R. M., Lowe, J. A., Nakanishi, S., & Schwartz, T. W. (1993) · Nature · doi:10.1038/362345a0 · Cited by 210
Thompson, S. M., & Gähwiler, B. H. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019167 · Cited by 210
Antidepressant effects of nicotine in an animal model of depression
Tizabi, Y., Overstreet, D. H., Rezvani, A. H., Louis, V. A., Clark Jr, E., Janowsky, D. S., & Kling, M. A. (1999) · Psychopharmacology · doi:10.1007/s002130050879 · Cited by 209
Carpenter, L. L., Tyrka, A. R., McDougle, C. J., Malison, R. T., Owens, M. J., Nemeroff, C. B., & Price, L. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300375 · Cited by 209
Bockaert, J., Claeysen, S., Compan, V, & Dumuis, A. (2004) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007043482615 · Cited by 209
Tam, S. W., Worcel, M., & Wyllie, M. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00156-5 · Cited by 209
Sitte, H. H., Huck, S., Reither, H., Boehm, S., Singer, E. A., & Pifl, C. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71031289.x · Cited by 209
A Family of Highly Selective Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5
O’Brien, J. A., Lemaire, W., Chen, T.-B., Chang, R. S. L., Jacobson, M. A., Ha, S. N., Lindsley, C. W., Schaffhauser, H. J., Sur, C., Pettibone, D. J., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.731 · Cited by 209
Mayorga, A. J., Dalvi, A., Page, M. E., Zimov-Levinson, S., Hen, R., & Lucki, I. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29479-9 · Cited by 209
The mesolimbic dopamine system as a target for rapid antidepressant action
Willner, P. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199707003-00002 · Cited by 208
An association between depression, anxiety and thyroid function – a clinical fact or an artefact?
Engum, A., Bjøro, T., Mykletun, A., & Dahl, A. A. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.01250.x · Cited by 208
Michael, N., Erfurth, A., Ohrmann, P., Arolt, V., Heindel, W., & Pfleiderer, B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300085 · Cited by 208
Fava, M., Thase, M. E., & DeBattista, C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0112 · Cited by 207
Redrobe, J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00403-1 · Cited by 207
In vivo gene modification elucidates subtype-specific functions of alpha(2)-adrenergic receptors.
Kable, J. W., Murrin, L. C., & Bylund, D. B. (2000) · PubMed · Cited by 207
Ayoub, M. A., Levoye, A., Delagrange, P., & Jockers, R. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000398 · Cited by 207
The role of dopamine in the nucleus accumbens and striatum during sexual behavior in the female rat
Becker, J. B., Rudick, C. N., & Jenkins, W. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03236.2001 · Cited by 206
PKA isoforms, neural pathways, and behaviour: making the connection
Brandon, E. P., Idzerda, R. L., & McKnight, G. S. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80069-4 · Cited by 206
Effects of antidepressants on cognitive functions: a review
Amado-Boccara, I. (1995) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)00068-c · Cited by 206
A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze
Woolley, M. L., Bentley, J. C., Sleight, A. J., Marsden, C. A., & Fone, K. C. F. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00056-9 · Cited by 206
Cryan, J. F., Kelly, P. H., Chaperon, F., Gentsch, C., Mombereau, C., Lingenhoehl, K., Froestl, W., Bettler, B., Kaupmann, K., & Spooren, W. P. J. M. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.066753 · Cited by 206
Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction
Montgomery, S. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00313-5 · Cited by 205
Non-genomic effects of glucocorticoids in the neural system
Makara, G. B., & Haller, J. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00012-0 · Cited by 205
Unraveling the Mechanism of Protein N-Glycosylation
Yan, A., & Lennarz, W. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.r400036200 · Cited by 205
Overview of phosphodiesterase 5 inhibition in erectile dysfunction
Rosen, R. C., & Kostis, J. B. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00824-5 · Cited by 205
Neurobiological Effects of Sex Steroid Hormones
(1995) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529832 · Cited by 204
GABAB receptor activation enhances mGluR-mediated responses at cerebellar excitatory synapses
Hirono, M., Yoshioka, T., & Konishi, S. (2001) · Nature Neuroscience · doi:10.1038/nn764 · Cited by 204
Bomholt, S. F., Mikkelsen, J. D., & Blackburn-Munro, G. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.012 · Cited by 204
Neumaier, J. F., Sexton, T. J., Yracheta, J., Diaz, A. M., & Brownfield, M. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00092-2 · Cited by 204
The tachykinin NK1 receptor in the brain: pharmacology and putative functions
Saria, A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00259-9 · Cited by 204
Why does the rapid delivery of drugs to the brain promote addiction?
Samaha, A.-N., & Robinson, T. E. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.12.007 · Cited by 204
Cannabis use and the risk of later schizophrenia: a review
Smit, F., Bolier, L., & Cuijpers, P. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00683.x · Cited by 203
Neurosteroids in depression: a review
van Broekhoven, F., & Verkes, R. J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1257-1 · Cited by 203
Blank, T., Nijholt, I., Grammatopoulos, D. K., Randeva, H. S., Hillhouse, E. W., & Spiess, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-02-00700.2003 · Cited by 202
Roberts, R. L., Joyce, P. R., Mulder, R. T., Begg, E. J., & Kennedy, M. A. (2002) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500099 · Cited by 202
Central nervous system pharmacology of neuropeptide Y
Wettstein, J. G., Earley, B., & Junien, J. L. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)98598-k · Cited by 202
Vickers, S. P., Dourish, C. T., & Kennett, G. A. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00063-6 · Cited by 202
Pehek, E. A., Nocjar, C., Roth, B. L., Byrd, T. A., & Mabrouk, O. S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300819 · Cited by 202
Increased Exploratory Activity and Altered Response to LSD in Mice Lacking the 5-HT5A Receptor
Grailhe, R., Waeber, C., Dulawa, S. C., Hornung, J. P., Zhuang, X., Brunner, D., Geyer, M. A., & Hen, R. (1999) · Neuron · doi:10.1016/s0896-6273(00)80712-6 · Cited by 202
Modafinil Augmentation of Antidepressant Treatment in Depression
Menza, M. A., Kaufman, K. R., & Castellanos, A. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0510 · Cited by 202
Murphy, D. L., Mueller, E. A., Hill, J. L., Tolliver, T. J., & Jacobsen, F. M. (1989) · Psychopharmacology · doi:10.1007/bf00444705 · Cited by 201
Shirazi-Southall, S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00400-6 · Cited by 201
Lucassen, P. J., Fuchs, E., & Czéh, B. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.014 · Cited by 201
Selective Optimization of Side Activities: Another Way for Drug Discovery
Wermuth, C. G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030480f · Cited by 201
Landen, M., Eriksson, E., Agren, H., & Fahlen, T. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199906000-00012 · Cited by 201
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
Sacco, K. A., Bannon, K. L., & George, T. P. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104047273 · Cited by 201
Moore, P. K., & Handy, R. L. C. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01064-x · Cited by 200
Nitric oxide increases dopamine and serotonin release in the medial preoptic area
Lorrain, D. S., & Hull, E. M. (1993) · NeuroReport · doi:10.1097/00001756-199310000-00024 · Cited by 200
Binet, V., Brajon, C., Le Corre, L., Acher, F., Pin, J.-P., & Prézeau, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400930200 · Cited by 200
Aracava, Y., Pereira, E. F. R., Maelicke, A., & Albuquerque, E. X. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077172 · Cited by 200
Rammes, G., Rupprecht, R., Ferrari, U., Zieglgänsberger, W., & Parsons, C. G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01872-9 · Cited by 200
Human brain fluoxetine concentrations
(1993) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.5.3.322 · Cited by 200
Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression.
Goodwin, G. M. (1997) · Journal of Psychopharmacology · doi:10.1177/026988119701100204 · Cited by 199
Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms
Robertson, G., & Robertson, H. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-09-03326.1989 · Cited by 198
A Single Subunit (GB2) Is Required for G-protein Activation by the Heterodimeric GABAB Receptor
Duthey, B., Caudron, S., Perroy, J., Bettler, B., Fagni, L., Pin, J.-P., & Prézeau, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108900200 · Cited by 198
Keck, M. E., & Holsboer, F. (2001) · Peptides · doi:10.1016/s0196-9781(01)00398-9 · Cited by 198
Convergent evolution of gene circuits
Conant, G. C., & Wagner, A. (2003) · Nature Genetics · doi:10.1038/ng1181 · Cited by 198
Polyspecific organic cation transporters: their functions and interactions with drugs
Koepsell, H. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.05.005 · Cited by 198
Hawes, B. E. (2000) · Endocrinology · doi:10.1210/en.141.12.4524 · Cited by 198
Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration
Hensler, J. G. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02482-7 · Cited by 198
Paroxetine Treatment of Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled Study
Rickels, K., Zaninelli, R., McCafferty, J., Bellew, K., Iyengar, M., & Sheehan, D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.749 · Cited by 198
King, M. V., Sleight, A. J., Woolley, M. L., Topham, I. A., Marsden, C. A., & Fone, K. C. F. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.03.012 · Cited by 197
Wang, Q., O'Brien, P. J., Chen, C., Cho, D. C., Murray, J. M., & Nishikura, K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.741290.x · Cited by 197
Making protein interactions druggable: targeting PDZ domains
Dev, K. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1578 · Cited by 197
Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor
Pälvimäki, E. P., Majasuo, H., Laakso, A., Kuoppamäki, M., Syvälahti, E., Roth, B. L., & Hietala, J. (1996) · Psychopharmacology · doi:10.1007/bf02246453 · Cited by 197
Mantovani, M., Pértile, R., Calixto, J. B., Santos, A. R. S., & Rodrigues, A. L. S. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00306-9 · Cited by 197
Conservation and Coevolution in the Scale-Free Human Gene Coexpression Network
Jordan, I. K., Mariño-Ramírez, L., Wolf, Y. I., & Koonin, E. V. (2004) · Molecular Biology and Evolution · doi:10.1093/molbev/msh222 · Cited by 197
Seasonal Affective Disorder: An Overview: REVIEW
Magnusson, A., & Boivin, D. (2003) · Chronobiology International · doi:10.1081/cbi-120019310 · Cited by 196
Overbeek, T., Schruers, K., Vermetten, E., & Griez, E. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1204 · Cited by 196
Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP.
Miller, K. J., & Hoffman, B. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46992-x · Cited by 196
Montgomery, S. A., Kennedy, S. H., Burrows, G. D., Lejoyeux, M., & Hindmarch, I. (2004) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000137184.64610.c8 · Cited by 196
Stress-induced structural remodeling in hippocampus: Prevention by lithium treatment
Wood, G. E., Young, L. T., Reagan, L. P., Chen, B., & McEwen, B. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400208101 · Cited by 196
Inferring network mechanisms: The Drosophila melanogaster protein interaction network
Middendorf, M., Ziv, E., & Wiggins, C. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409515102 · Cited by 196
The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission
de Boer, T. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199512004-00004 · Cited by 196
Chapter 12 Forebrain nuclei involved in autonomic control
Loewy, A. D. (1991) · Progress in Brain Research · doi:10.1016/s0079-6123(08)63055-1 · Cited by 196
BDNF‐mediated signal transduction is modulated by GSK3β and mood stabilizing agents
Mai, L., Jope, R. S., & Li, X. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00939.x · Cited by 195
Dopamine D2 Long Receptor-Deficient Mice Display Alterations in Striatum-Dependent Functions
Wang, Y., Xu, R., Sasaoka, T., Tonegawa, S., Kung, M.-P., & Sankoorikal, E.-B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08305.2000 · Cited by 195
Rollema, H., Lu, Y., Schmidt, A. W., Sprouse, J. S., & Zorn, S. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00850-7 · Cited by 195
Behavioral effects of α-MSH and MCH after central administration in the female rat
Gonzalez, M. I., Vaziri, S., & Wilson, C. A. (1996) · Peptides · doi:10.1016/0196-9781(95)02092-6 · Cited by 195
Liston, D. R., Nielsen, J. A., Villalobos, A., Chapin, D., Jones, S. B., Hubbard, S. T., Shalaby, I. A., Ramirez, A., Nason, D., & White, W. F. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.080 · Cited by 195
Neurosteroid Biosynthesis in the Human Brain and Its Clinical Implications
STOFFEL‐WAGNER, B. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1286.007 · Cited by 195
Martinot, M.-L. P., Bragulat, V., Artiges, E., Dollé, F., Hinnen, F., Jouvent, R., & Martinot, J.-L. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.314 · Cited by 194
(1996) · PubMed · Cited by 194
Lipton, S. A. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6s610 · Cited by 194
Ströhle, A., Romeo, E., Hermann, B., Pasini, A., Spalletta, G., di Michele, F., Holsboer, F., & Rupprecht, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00328-x · Cited by 194
Topological generalizations of network motifs
Kashtan, N., Itzkovitz, S., Milo, R., & Alon, U. (2004) · Physical Review E · doi:10.1103/physreve.70.031909 · Cited by 194
Millan, M. J., Newman-Tancredi, A., Audinot, V., Cussac, D., Lejeune, F., Nicolas, J.-P., Cog�, F., Galizzi, J.-P., Boutin, J. A., Rivet, J.-M., et al. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200002)35:2<79::aid-syn1>3.0.co;2-x · Cited by 194
Self-citationNewman-Tancredi, A., Cussac, D., Quentric, Y., Touzard, M., Verrièle, L., Carpentier, N., & Millan, M. J. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039883 · Cited by 194
Self-citationChrapko, W. E., Jurasz, P., Radomski, M. W., Lara, N., Archer, S. L., & Le Mellédo, J.-M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.003 · Cited by 193
Discovery of an Ectopic Activation Site on the M1Muscarinic Receptor
Spalding, T. A., Trotter, C., Skjærbæk, N., Messier, T. L., Currier, E. A., Burstein, E. S., Li, D., Hacksell, U., & Brann, M. R. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12088-3 · Cited by 193
SGS742: the first GABAB receptor antagonist in clinical trials
Froestl, W., Gallagher, M., Jenkins, H., Madrid, A., Melcher, T., Teichman, S., Mondadori, C. G., & Pearlman, R. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.030 · Cited by 193
Parkinson’s disease and anxiety
Walsh, K., & Bennett, G. (2001) · Postgraduate Medical Journal · doi:10.1136/pmj.77.904.89 · Cited by 193
Cytochrome P450: What Have We Learned and What Are the Future Issues?
Peter Guengerich, F. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-120033996 · Cited by 193
A Noradrenergic and Serotonergic Hypothesis of the Linkage Between Epilepsy and Affective Disorders
Jobe, P. C., Dailey, J. W., & Wernicke, J. F. (1999) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v13.i4.10 · Cited by 193
Mosimann, U. P., Schmitt, W., Greenberg, B. D., Kosel, M., Müri, R. M., Berkhoff, M., Hess, C. W., Fisch, H. U., & Schlaepfer, T. E. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2003.10.006 · Cited by 192
Miller, H. L. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020031005 · Cited by 192
Blier, P., & de Montigny, C. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00114-0 · Cited by 192
Dose-dependent suppression of adrenocortical activity with metyrapone: Effects on emotion and memory
Roozendaall, B., Bohus, B., & McGaugh, J. L. (1996) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(96)00028-5 · Cited by 192
Neurogenesis and depression: etiology or epiphenomenon?
Henn, F. A., & Vollmayr, B. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.04.011 · Cited by 192
Jorge, R. E., Robinson, R. G., Tateno, A., Narushima, K., Acion, L., Moser, D., Arndt, S., & Chemerinski, E. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.017 · Cited by 192
Borowsky, B., Durkin, M. M., Ogozalek, K., Marzabadi, M. R., DeLeon, J., Heurich, R., Lichtblau, H., Shaposhnik, Z., Daniewska, I., Blackburn, T. P., et al. (2002) · Nature Medicine · doi:10.1038/nm0902-1039b · Cited by 192
New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine
Brunello, N. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00068-o · Cited by 191
Serotonin autoreceptor function and antidepressant drug action
Hjorth, S., Bengtsson, H. J., Kullberg, A., Carlzon, D., Peilot, H., & Auerbach, S. B. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400208 · Cited by 191
Principles: Extending the utility of [35S]GTPγS binding assays
Milligan, G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)00027-5 · Cited by 191
Dringenberg, H. C. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00261-8 · Cited by 191
Zubenko, G. S., Maher, B., Hughes, H. B., Zubenko, W. N., Stiffler, J. S., Kaplan, B. B., & Marazita, M. L. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20073 · Cited by 191
Moscrip, T. D., Terrace, H. S., Sackeim, H. A., & Lisanby, S. H. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570500578x · Cited by 191
Cited by
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Metadata
- Authors
- Millan, M. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 110
- Issue
- 2
- Pages
- 135-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2073570537
- Cited by
- 551
- References
- 3,517
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.